Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane

Cellular Microbiology

Volumn 8, Issue 12, 2006, Pages 1922-1931

  Lodge, Robert ^a   Diallo, Tamsir O ^a   Descoteaux, Albert ^a  

^a Department of Microbiology and Immunology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPHOSPHOGLYCAN; PROTEIN P47; PROTEIN P67; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RHO GUANOSINE TRIPHOSPHATASE; SUPEROXIDE;

ARTICLE; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEFENSE MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; LEISHMANIA DONOVANI; MEMBRANE COMPONENT; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; WILD TYPE;

ANIMALS; FEMALE; GLYCOSPHINGOLIPIDS; INTRACELLULAR MEMBRANES; LEISHMANIA DONOVANI; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NADPH OXIDASE; PHAGOCYTOSIS; PHAGOSOMES; PHOSPHOPROTEINS; SUPEROXIDES;

LEISHMANIA DONOVANI;

EID: 33750611352     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2006.00758.x     Document Type: Article

References (51)

1. Allen, L.A., Beecher, B.R., Lynch, J.T., Rohner, O.V., and Wittine, L.M. (2005) Helicobacter pylori disrupts NADPH oxidase targeting in human neutrophils to induce extracellular superoxide release. J Immunol 174: 3658-3667.
2. Amer, A.O., and Swanson, M.S. (2002) A phagosome of one's own: A microbial guide to life in the macrophage. Curr Opin Microbiol 5: 56-61.
3. Babior, B.M., Lambeth, J.D., and Nauseef, W. (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344.
4. Baehner, R.L., Boxer, L.A., and Davis, J. (1976) The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood 48: 309-313.
5. Bates, P.A., Hermes, I., and Dwyer, D.M. (1990) Golgi-mediated post-translational processing of secretory acid phosphatase by Leishmania donovani promastigotes. Mol Biochem Parasitol 39: 247-255.
6. Bokoch, G.M., and Diebold, B.A. (2002) Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100: 2692-2696.
7. Breton, A., and Descoteaux, A. (2000) Protein kinase Cα participates in FcγR-mediated phagocytosis in macrophages. Biochem Biophys Res Commun 276: 472-476.
8. Brittingham, A., Morrison, C.J., McMaster, W.R., McGwire, B.S., Chang, K.P., and Mosser, D.M. (1995) Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol 155: 3102-3111.
9. Brown, G.E., Stewart, M.Q., Liu, H., Ha, V.L., and Yaffe, M.B. (2003) A novel assay system implicates PtdIns (3,4) P (2), PtdIns (3) P, and PKC δ in intracellular production of reactive oxygen species by the NADPH oxidase. Mol Cell 11: 35-47.
10. Chan, J., Fujiwara, T., Brennan, P., McNeil, M., Turco, S.J., Sibille, J.C., et al. (1989) Microbial glycolipids: Possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci USA 86: 2453-2457.
11. Cooper, A., Rosen, H., and Blackwell, J.M. (1988) Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle. Immunology 65: 511-514.
12. Dermine, J.-F., Scianimanico, S., Privé, C., Descoteaux, A., and Desjardins, M. (2000) Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis. Cell Microbiol 2: 115-126.
13. Dermine, J.F., Duclos, S., Garin, J., St-Louis, F., Rea, S., Parton, R.G., and Desjardins, M. (2001) Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 276: 18507-18512.
14. Dermine, J.F., Goyette, G., Houde, M., Turco, S.J., and Desjardins, M. (2005) Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell Microbiol 7: 1263-1270.
15. Descoteaux, A., and Turco, S.J. (1999) Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta 1455: 341-352.
16. Descoteaux, A., Luo, Y., Turco, S.J., and Beverley, S.M. (1995) A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 269: 1869-1872.
17. Desjardins, M., and Descoteaux, A. (1997) Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 185: 2061-2068.
18. Dinauer, M.C., and Orkin, S.H. (1992) Chronic granulomatous disease. Annu Rev Med 43: 117-124.
19. Fairlamb, A.H., and Cerami, A. (1992) Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 46: 695-729.
20. Gallois, A., Klein, J.R., Allen, L.A., Jones, B.D., and Nauseef, W.M. (2001) Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J Immunol 166: 5741-5748.
21. Gantt, K.R., Goldman, T.L., McCormick, M.L., Miller, M.A., Jeronimo, S.M., Nascimento, E.T., et al. (2001) Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 167: 893-901.
22. Gueron, E., Isakov, N., and el-On, J. (1993) Leishmania major: respiratory burst response of infected murine macrophages treated with paromomycin. Exp Parasitol 76: 371-376.
23. Holm, Å., Tejle, K., Magnusson, K.E., Descoteaux, A., and Rasmusson, B. (2001) Leishmania donovani lipophosphoglycan causes periphagosomal actin accumulation: Correlation with impaired translocation of PKCα and defective phagosome maturation. Cell Microbiol 3: 439-447.
24. Huang, C., and Turco, S.J. (1993) Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani. J Biol Chem 268: 24060-24066.
25. Ilg, T. (2000) Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J 19: 1953-1962.
26. Ilg, T., Stierhof, Y.D., Craik, D., Simpson, R., Handman, E., and Bacic, A. (1996) Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J Biol Chem 271: 21583-21596.
27. Johnston, R.B., Jr, Godzik, C.A., and Cohn, Z.A. (1978) Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J Exp Med 148: 115-127.
28. Laroux, F.S., Romero, X., Wetzler, L., Engel, P., and Terhorst, C. (2005) Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of Gram-negative bacteria. J Immunol 175: 5596-5600.
29. Le Cabec, V., Cols, C., and Maridonneau-Parini, I. (2000) Nonopsonic phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun 68: 4736-4745.
30. Lodge, R., and Descoteaux, A. (2005) Leishmania donovani promastigotes induce periphagosomal F-actin accumulation through retention of the GTPase Cdc42. Cell Microbiol 7: 1647-1658.
31. McNeely, T.B., and Turco, S.J. (1990) Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J Immunol 144: 2745-2750.
32. McNeely, T.B., Tolson, D.L., Pearson, T.W., and Turco, S.J. (1990) Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies. Glycobiology 1: 63-69.
33. Murray, H.W. (1981) Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages. J Exp Med 153: 1302-1315.
34. Nauseef, W.M. (2004) Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122: 277-291.
35. Pearson, R.D., and Steigbigel, R.T. (1981) Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes. J Immunol 127: 1438-1443.
36. Perisic, O., Wilson, M.I., Karathanassis, D., Bravo, J., Pacold, M.E., Ellson, C.D., et al. (2004) The role of phosphoinositides and phosphorylation in regulation of NADPH oxidase. Adv Enzyme Regul 44: 279-298.
37. Privé, C., and Descoteaux, A. (2000) Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol 30: 2235-2244.
38. Rosenthal, L.A., Sutterwala, F.S., Kehrli, M.E., and Mosser, D.M. (1996) Leishmania major -human macrophage interactions: Cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect Immun 64: 2206-2215.
39. Russell, D.G. (1987) The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. Eur J Biochem 164: 213-221.
40. Scianimanico, S., Desrosiers, M., Dermine, J.-F., Méresse, S., Descoteaux, A., and Desjardins, M. (1999) Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes. Cell Microbiol 1: 19-32.
41. Shao, D., Segal, A.W., and Dekker, L.V. (2003) Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550: 101-106.
42. Shatwell, K.P., and Segal, A.W. (1996) NADPH oxidase. Int J Biochem Cell Biol 28: 1191-1195.
43. Späth, G.F., Epstein, L., Leader, B., Singer, S.M., Avila, H.A., Turco, S.J., and Beverley, S.M. (2000) Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci USA 97: 9258-9263.
44. Späth, G.F., Garraway, L.A., Turco, S.J., and Beverley, S.M. (2003) The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc Natl Acad Sci USA 100: 9536-9541.
45. Tolson, D.L., Turco, S.J., and Pearson, T.W. (1990) Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect Immun 58: 3500-3507.
46. Turco, S.J., and Descoteaux, A. (1992) The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol 46: 65-94.
47. Turco, S.J., Späth, G.F., and Beverley, S.M. (2001) Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol 17: 223-226.
48. Vazquez-Torres, A., Xu, Y., Jones-Carson, J., Holden, D.W., Lucia, S.M., Dinauer, M.C., et al. (2000) Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287: 1655-1658.
49. Vazquez-Torres, A., Fantuzzi, G., Edwards, C.K., III, Dinarello, C.A., and Fang, F.C. (2001) Defective localization of the NADPH phagocyte oxidase to Salmonella -containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc Natl Acad Sci USA 98: 2561-2565.
50. Vilhardt, F., and Van Deurs, B. (2004) The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739-748.
51. Waterman, S.R., and Holden, D.W. (2003) Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system. Cell Microbiol 5: 501-511.